| Category: |
Antibody |
| Concentration: |
09% sodium azide, 4 with 0, In 1X PBS pH 7 |
| Form: |
Purified |
| Conjugation: |
Unconjugated |
| Clone: |
Polyclonal antibody |
| Recognised antigen: |
APOA4 |
| Host animal: |
Rabbit (Oryctolagus cuniculus) |
| Clonality: |
Polyclonal (rabbit origin) |
| Species reactivity: |
Due to limited knowledge and inability to test the antibody against all known species, we cannot guarantee that no other cross reactivity can occur, Human (Homo sapiens) |
| Tested applications: |
ELISA, IHC, WB |
| Recommended dilutions: |
IHC (Paraffin): 1:10-1:50, Western blot: 1:1000 |
| Notes: |
Titration of the APOA4 antibody may be required due to differences in protocols and secondary/substrate sensitivity |
| Intented use: |
This APOA4 antibodyis to be used only for research purposes and not for diagnostics |
| Uniprot #: |
P06727 |
| Purity: |
Purified |
| Description: |
Although its precise function is not known, apo A-IV is a potent activator of lecithin-cholesterol acyltransferase in vitro, in association with chylomicron particles, the intestine, The primary translation product of the APOA4 gene is a 396-residue preprotein which after proteolytic processing is secreted into its primary site of synthesis |
| Immunogen: |
A portion of amino acids 49-79 from the human protein was used as the immunogen for this APOA4 antibody |
| Storage: |
Celcius or lower, Cycles of freezing and thawing can denaturate the peptide chains of the antibodies and reduce their sensitivity and/or change their affinity, Prepare aliqotes in such a manner so that freeze-thaw cycles are minimized, Aliquot the APOA4 antibody and store frozen at -20 deg |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by NJS poly they should be stored frozen at - 24° |
| Gene target: |
APOA4 |
| Short name: |
APOA4 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
apolipoprotein A-IV (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
APOA4 and IDBG-630787 and ENSBTAG00000019770 and 537301, APOA4 and IDBG-72499 and ENSG00000110244 and 337, Apoa4 and IDBG-161288 and ENSMUSG00000032080 and 11808, Extracellular, phosphatidylcholine-sterol O-acyltransferase activator activity, this GO :0001523 and retinoid metabolic process and biological process this GO :0002227 and innate immune response in mucosa and biological process this GO :0005319 and lipid transporter activity and molecular function this GO :0005507 and copper ion binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005769 and early endosome and cellular component this GO :0005788 and endoplasmic reticulum lumen and cellular component this GO :0005829 and cytosol and cellular component this GO :0006869 and lipid transport and biological process this GO :0006982 and response to lipid hydroperoxide and biological process this GO :0007159 and leukocyte cell-cell adhesion and biological process this GO :0007603 and phototransduction, this GO :0005319 : lipid transporter activity, this GO :0005319 : lipid transporter activity and also this GO :0005507 : copper ion binding and also this GO :0008289 : lipid binding and also this GO :0016209 : antioxidant activity and also this GO :0017127 : cholesterol transporter activity and also this GO :0031210 : phosphatidylcholine binding and also this GO :0042803 : protein homodimerization activity and also this GO :0060228 : phosphatidylcholine-sterol O-acyltransferase activator activity, this GO :0005507 : copper ion binding, this GO :0008289 : lipid binding, this GO :0016209 : antioxidant activity, this GO :0017127 : cholesterol transporter activity, this GO :0031210 : phosphatidylcholine binding, this GO :0042803 : protein homodimerization activity, this GO :0060228 : phosphatidylcholine-sterol O-acyltransferase activator activity, visible light and biological process this GO :0008203 and cholesterol metabolic process and biological process this GO :0008289 and lipid binding and molecular function this GO :0009986 and cell surface and cellular component this GO :0010873 and positive regulation of cholesterol esterification and biological process this GO :0010898 and positive regulation of triglyceride catabolic process and biological process this GO :0016209 and antioxidant activity and molecular function this GO :0017127 and cholesterol transporter activity and molecular function this GO :0019430 and removal of superoxide radicals and biological process this GO :0030300 and regulation of intestinal cholesterol absorption and biological process this GO :0031210 and phosphatidylcholine binding and molecular function this GO :0032374 and regulation of cholesterol transport and biological process this GO :0033344 and cholesterol efflux and biological process this GO :0033700 and phospholipid efflux and biological process this GO :0034361 and very-low-density lipoprotein particle and cellular component this GO :0034364 and high-density lipoprotein particle and cellular component this GO :0034371 and chylomicron remodeling and biological process this GO :0034372 and very-low-density lipoprotein particle remodeling and biological process this GO :0034375 and high-density lipoprotein particle remodeling and biological process this GO :0034378 and chylomicron assembly and biological process this GO :0034445 and negative regulation of plasma lipoprotein particle oxidation and biological process this GO :0035634 and response to stilbenoid and biological process this GO :0042157 and lipoprotein metabolic process and biological process this GO :0042627 and chylomicron and cellular component this GO :0042632 and cholesterol homeostasis and biological process this GO :0042744 and hydrogen peroxide catabolic process and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0043691 and reverse cholesterol transport and biological process this GO :0044240 and multicellular organismal lipid catabolic process and biological process this GO :0044281 and small molecule metabolic process and biological process this GO :0045723 and positive regulation of fatty acid biosynthetic process and biological process this GO :0046470 and phosphatidylcholine metabolic process and biological process this GO :0051006 and positive regulation of lipoprotein lipase activity and biological process this GO :0055088 and lipid homeostasis and biological process this GO :0060228 and phosphatidylcholine-sterol O-acyltransferase activator activity and molecular function this GO :0065005 and protein-lipid complex assembly and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0072562 and blood microparticle and cellular component, apolipoprotein A-IV |
| Identity: |
602 |
| Gene: |
APOA4 |
More about : APOA4 |
| Long gene name: |
apolipoprotein A4 |
| Synonyms gene name: |
apolipoprotein A-IV |
| Locus: |
11q23, 3 |
| Discovery year: |
2001-06-22 |
| Entrez gene record: |
337 |
| RefSeq identity: |
NM_000482 |
| Classification: |
Apolipoproteins |
| Havana BLAST/BLAT: |
OTTHUMG00000046110 |